前列腺体积在良性前列腺增生治疗中的意义
摘要
药物治疗在良性前列腺增生（BPH）的治疗中占有非常重要的地位，近90％的患者接受药物治疗。不同药物具有不同的治疗靶点，但其应用都应遵循BPH的临床治疗原则。中国BPH诊治指南推荐的BPH患者药物治疗的短期目标为缓解患者的下尿路症状（LUTS），长期目标为延缓疾病的临床进展及预防合并症的发生，在减少药物治疗不良反应的同时保持患者较高的生活质量是BPH药物治疗的总体目标。
出处
《中华老年医学杂志》
CAS
CSCD
北大核心
2009年第7期543-545,共3页
Chinese Journal of Geriatrics
参考文献19
-
1Roehrborn CG,McConnell JD.Etiology,pathothysiology,epidemiology and natural history of binign prostatic hyperplasia.In:PC Walsh,AB Retik,ED Vaughan,et al.Campbell's Urology.Philadelphia,PA:W.B.Saunders Company,2002.1297-1330.
-
2Berry MJ,Coffey DS,Walsh PC,et al.The development of human benign prostatic hyperplasia with age.J Urol,1984,132:474-478.
-
3Jacobsen SJ,Jacobson DJ,Girman CJ,et al.Treatment for benign prostatic hyperplasia among community dwelling men:the Olmsted County study of urinary symptoms and health status.J Urol,1999,162:1301-1306.
-
4Temml C,Brossner C,Schatzl G,et al.The natural history of lower urinary tract symptoms over 5 years.Eur Urol,2003,43:274-380.
-
5Jacobsen SJ,Jacobson DJ,Girman CJ,et al.Natural history of prostatism.,risk factors for acute urinary retention.J Urol,1997,158:481-487.
-
6Roehrborn CG,McConnell JD,Saltzman B,et al.Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcomes.Eur Urol,2002,42:1-6.
-
7Kaplan S,Garvin D,Gilhooly P,et al.Impact of baseline symptom severity on future risk of benign prostatic hyperplasia-related outcomes and long-term response to finasteride.The Pless Study Group.Urology,2000,56:610-616.
-
8McConnell JD,Roehrborn CG,Bautista OM,et al.The long-term effect of doxazosin,finasteride,and combination therapy on the clinical progression of benign prostatic hyperplasia.N Engl J Med,2003,349:2387-2398.
-
9Bruskewitz R,Girman CJ,Fowler J,et al.Effect of finasteride on bother and other health related quality of life aspects associated with benign prostatic hyperplasia.PLESS Study Group.Proscar Long-term Effcacy and Safety Study.Urology,1999,54:670-678.
-
10Roehrborn CG,Boyle P,Bergner D,et al.Serum prostate-specific antigen and prostate volume predict lone-term changes in symptoms and flow rate:results of a four years,randomised trial comparing finasteride versus placebo.PLESS Study Group.Urology,1999,54:662-669.
-
1吴沛珊,倪少滨.前列腺增生的保守治疗[J].中国社区医师,2013(33):6-7.
-
2高冰.前列腺增生 治疗用药要坚持[J].糖尿病之友,2008(5):42-42.
-
3陈志永,郁全胜,陈猛,崔勇,范建华.经尿道前列腺汽化电切术治疗前列腺增生的临床分析[J].黑龙江医药,2014,27(6):1410-1411. 被引量：4
-
4王建斌,唐宏召.经尿道等离子双极电切术治疗前列腺增生的疗效分析[J].当代医学,2015,21(13):50-51. 被引量：5
-
5黄鹏.前列腺电切术在前列腺增生治疗中的应用[J].包头医学院学报,2016,32(2):74-75.
-
6祁占涛.经尿道前列腺电切术治疗前列腺增生的临床分析[J].中国医学工程,2013,21(1):81-81. 被引量：1
-
7王晋,王仁顺.前列腺增生治疗的进展[J].人民军医,1995,38(1):46-47.
-
8胡建云,万能文,邓宏,陈国涛.经尿道双极等离子电切术治疗良性前列腺增生的临床效果[J].中国当代医药,2015,22(34):82-84. 被引量：16
-
9张向军,张殿廷.良性前列腺增生的激光治疗[J].临床外科杂志,2007,15(1):59-60. 被引量：4
-
10徐卫东.经尿道前列腺电切术176例诊疗体会[J].现代医药卫生,2004,20(24):2689-2689.
